goldennet

Non-invasive Prenatal Testing (NIPT)

All NIPT test items are certified by CAP international standards and analyzed using the exclusively patented GWNS algorithm. The entire process of checking babies' chromosomes is conducted in Taiwan, adhering to the most stringent and highest standard procedures to ensure accuracy and reliability.

SMA Genetic Testing

The carrier rate of Spinal Muscular Atrophy (SMA) is approximately 1 in 50. Genomics BioSci's SMA genetic testing is conducted in a TAF-certified laboratory registered for LDTs. With just a small blood sample, we can accurately determine genotype and carrier status

Fragile X Syndrome Genetic Testing

Fragile X Syndrome is a common genetic intellectual disorder. Genomics BioSci's Fragile X genetic testing is conducted in a TAF-certified laboratory registered for LDTs. By collecting a blood sample and extracting DNA, we can determine the FMR1 genotype of the test subject and assess their carrier status.

Microarray Assay

This assay utilizes the latest aCGH microarray chip, enhanced with probes specifically designed for detecting prenatal fetal genetic diseases in the Taiwanese population. It features up to 60,000 probes covering all 46 human chromosomes, with increased probe density in regions associated with known hereditary diseases, thereby enhancing analytical power.

PGS Preimplantation Genetic Screening

Whole-genome quantitative analysis using microarray technology, such as PGS testing, can prevent the implantation of embryos with abnormal chromosomes, thereby increasing the success rate of assisted reproduction.